SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $323,290 | -62.0% | 2,823 | -54.2% | 0.03% | -48.1% |
| Q1 2023 | $849,722 | -49.2% | 6,165 | -52.2% | 0.05% | -52.7% |
| Q4 2022 | $1,671,193 | +78.0% | 12,897 | +23.7% | 0.11% | +93.0% |
| Q4 2021 | $939,000 | +169.8% | 10,430 | +123.6% | 0.06% | +185.0% |
| Q1 2021 | $348,000 | -63.0% | 4,664 | -15.4% | 0.02% | -70.6% |
| Q4 2020 | $940,000 | -80.0% | 5,511 | -83.5% | 0.07% | -55.3% |
| Q3 2020 | $4,691,000 | -29.0% | 33,406 | -19.0% | 0.15% | -11.1% |
| Q2 2020 | $6,611,000 | +86.1% | 41,231 | +13.5% | 0.17% | +81.9% |
| Q1 2020 | $3,553,000 | +42.7% | 36,322 | +88.3% | 0.09% | +168.6% |
| Q4 2019 | $2,489,000 | +226.2% | 19,286 | +90.5% | 0.04% | +288.9% |
| Q3 2019 | $763,000 | +9.8% | 10,124 | +121.4% | 0.01% | -35.7% |
| Q2 2019 | $695,000 | -22.9% | 4,572 | -39.6% | 0.01% | -22.2% |
| Q1 2019 | $902,000 | -20.3% | 7,571 | -27.0% | 0.02% | -25.0% |
| Q4 2018 | $1,132,000 | +20.9% | 10,373 | +79.0% | 0.02% | +20.0% |
| Q3 2018 | $936,000 | +13.7% | 5,795 | -6.9% | 0.02% | -4.8% |
| Q2 2018 | $823,000 | +1.1% | 6,226 | -43.4% | 0.02% | -8.7% |
| Q1 2018 | $814,000 | – | 10,991 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |